Terms: = Gastric cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Staging
10 results:
1. CLDN5 identified as a biomarker for metastasis and immune infiltration in gastric cancer via pan-cancer analysis.
Han L; Cui DJ; Huang B; Yang Q; Huang T; Lin GY; Chen SJ
Aging (Albany NY); 2023 Jun; 15(11):5032-5051. PubMed ID: 37286335
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significances of PD-L1- and ctla-4-positive T cells and positive correlations of immunosuppressive marker expression between cancer tissue and peripheral blood in patients with gastric cancer.
Lee KH; Kim SJ; Woo JS; Lee SY; Jhun J; Moon J; Jung YJ; Cho ML; Song KY
Front Immunol; 2023; 14():1138743. PubMed ID: 37153541
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Value of PD-L1 Immunohistochemical Marker in gastric Carcinoma and Its Correlation with HER2 Status.
Attia S; Abd El Hafez A; Abdel-Aziz A; Elmetwaly S; Mokhtar N
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1433-1444. PubMed ID: 35485706
[TBL] [Abstract] [Full Text] [Related]
4. Co-Expression of LGR5 and CD133 cancer Stem Cell Predicts a Poor Prognosis in Patients With gastric cancer.
Wattanawongdon W; Bathpho TS; Tongtawee T
Turk J Gastroenterol; 2021 Mar; 32(3):261-268. PubMed ID: 34160355
[TBL] [Abstract] [Full Text] [Related]
5. gastric cancer, inflammatory bowel disease and polyautoimmunity in a 17-year-old boy: ctla-4 deficiency successfully treated with Abatacept.
Angelino G; Cifaldi C; Zangari P; Di Cesare S; Di Matteo G; Chiriaco M; Francalanci P; Faraci S; Rea F; Romeo EF; Amodio D; Ursu GM; Bertocchini A; Accinni A; Crocoli A; Inserra A; Cozza R; Romano C; Licciardello M; Rinelli M; Dall'Oglio L; Cancrini C; De Angelis P; Finocchi A
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1051-e1056. PubMed ID: 34034269
[TBL] [Abstract] [Full Text] [Related]
6. An Aggressive Form of MALT Lymphoma of the Stomach with Pancreas Infiltration.
Mulalic E; Delibegovic S
Med Arch; 2016 Jun; 70(3):235-7. PubMed ID: 27594756
[TBL] [Abstract] [Full Text] [Related]
7. [Promoter methylation of several tumor suppressor genes in human gastric adenocarcinoma].
Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):978-81. PubMed ID: 17650424
[TBL] [Abstract] [Full Text] [Related]
8. staging for CLL-type non-Hodgkin's lymphoma reveals a gastrointestinal stromal tumour.
Herbers AH; Keuning JJ
Neth J Med; 2005 Feb; 63(2):74-5. PubMed ID: 15766012
[TBL] [Abstract] [Full Text] [Related]
9. [The clinical significance of E-cadherin and alpha-catenin expression in human gastric cancer].
Dai D; Chen J; Xu H
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):35-8. PubMed ID: 11783066
[TBL] [Abstract] [Full Text] [Related]
10. Pathological study of alpha-chain disease, with special emphasis on evolution.
Galian A; Lecestre MJ; Scotto J; Bognel C; Matuchansky C; Rambaud JC
Cancer; 1977 May; 39(5):2081-101. PubMed ID: 404026
[TBL] [Abstract] [Full Text] [Related]
